Description
HIVp17Gag(77-85)isanimmunodominantGagepitopepeptideusedtoprimeactivatedCD8+cytotoxicTcells(CTLs)inthedesignofvaccinesagainstHIV-1.
HIVp17Gag(77-85)isanimmunodominantGagepitopepeptideusedtoprimeactivatedCD8+cytotoxicTcells(CTLs)inthedesignofvaccinesagainstHIV-1.
| Purity | ≥98% |
|---|---|
| Formula | C44H72N10O15 |
| FormulaWt. | 981.1 |
| Synonym | HIV-1p17(77-85);SL9. |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | H3274InfoSheetPDF |
|---|
Kan-MitchellJ,BajczM,SchaubertKL,etal.DegeneracyandrepertoireofthehumanHIV-1Gagp17(77-85)CTLresponse.JImmunol.2006Jun1;176(11):6690-701.PMID:16709828.
Kan-MitchellJ,BisikirskaB,Wong-StaalF,etal.TheHIV-1HLA-A2-SLYNTVATLisahelp-independentCTLepitope.JImmunol.2004May1;172(9):5249-61.PMID:15100263.